Common side effects associated with retatrutide consistent with the broader GLP-1 receptor agonist class, as described in the Summary of Product Characteristics (SmPC) for licensed medicines such as Wegovy (semaglutide 2.4 mg) and Mounjaro (tirzepatide) include: Nausea (particularly during dose escalation) Vomiting Diarrhoea or constipation Decreased appetite Injection site reactions such as mild redness or discomfort Increased heart rate , which has been observed with incretin-based therapies These gastrointestinal effects are typically most pronounced when starting treatment or increasing the dose, and they often improve over time as the body adjusts
For Ozempic and Wegovy, you can also call Novo Nordisk directly at 1-800-727-6500
If you are still hungry in the first 8 to 12 weeks, you are likely just waiting for your body to reach the therapeutic levels validated in these clinical studies
How is bupropion prescribed for weight loss
SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis
Synthetic hormones have a different structure than bioidentical hormones and may produce divergent effects within the cardiovascular system as compared to bioidentical hormones
